The 116 th Congress continues its interest in U.S. research and development (R&D) and in evaluating support for federal R&D activities. The federal government has played an important role in supporting R&D efforts that have led to scientific breakthroughs and new technologies, from jet aircraft and the internet to communications satellites, shale gas extraction, and defenses against disease. In recent years, federal budget caps have driven executive and legislative branch decisions about the prioritization of R&D, both in the context of the entire federal budget and among competing needs within the federal R&D portfolio. The Bipartisan Budget Act of 2019, among other things, increased the previously established FY2020 and FY2021 discretionary spending limits for defense and nondefense spending. This act reduced some of the budgetary constraints affecting R&D decisions. The U.S. government supports a broad range of scientific and engineering R&D. Its purposes include addressing national defense, health, safety, the environment, and energy security; advancing knowledge generally; developing the scientific and engineering workforce; and strengthening U.S. innovation and competitiveness in the global economy. Most of the R&D funded by the federal government is performed in support of the unique missions of individual funding agencies. The federal R&D budget is an aggregation of the R&D activities of these agencies. There is no single, centralized source of R&D funds. Agency R&D budgets are developed internally as part of each agency's overall budget development process. R&D funding may be included either in accounts that are entirely devoted to R&D or in accounts that also include funding for non-R&D activities. Agency budgets are subjected to review, revision, and approval by the Office of Management and Budget (OMB) and become part of the President's annual budget submission to Congress. The federal R&D budget is then calculated by aggregating the R&D activities of each federal agency. Congress plays a central role in defining the nation's R&D priorities as it makes decisions about the level and allocation of R&D fundingâoverall, within agencies, and for specific programs. In recent years, some Members of Congress have expressed concerns about the level of federal spending (for R&D and for other purposes) in light of the federal deficit and debt. Other Members of Congress have expressed support for increased federal spending for R&D as an investment in the nation's future competitiveness. As Congress acts to complete the FY2021 appropriations process, it faces two overarching issues: the amount of the federal budget to be spent on federal R&D and the prioritization and allocation of the available funding. This report begins with a discussion of the overall level of R&D in President Trump's FY2021 budget request, followed by analyses of R&D funding in the request from a variety of perspectives and for selected multiagency R&D initiatives. The remainder of the report discusses and analyzes the R&D budget requests of selected federal departments and agencies that, collectively, account for approximately 98% of total federal R&D funding. Selected terms associated with federal R&D funding are defined in the text box on the next page. Appendix A provides a list of acronyms and abbreviations. On February 10, 2020, President Trump released his proposed FY2021 budget. President Trump is proposing $142.2 billion for R&D for FY2021, a decrease of $13.8 billion (8.8%) below the FY2020 level of $156.0 billion. Adjusted for inflation to FY2021 dollars, the President's FY2021 R&D request represents a constant-dollar decrease of 10.6% from the FY2020 actual level. The President's request includes continued R&D funding for existing single-agency and multiagency programs and activities, as well as new initiatives. This report provides government-wide, multiagency, and individual agency analyses of the President's FY2021 request as it relates to R&D and related activities. Additional information and analysis will be included as the House and Senate act on the President's budget request through appropriations bills. It is not yet clear how the national response to the Coronavirus Disease 2019 (COVID-19) pandemic will affect Administration and congressional priorities for FY2021 R&D funding, or the congressional authorization and appropriations processes for enacting that funding. Federal R&D funding can be analyzed from a variety of perspectives that provide different insights. The following sections examine the data by agency, by the character of the work supported, and by a combination of these two perspectives. Congress makes decisions about R&D funding through the authorization and appropriations processes primarily from the perspective of individual agencies and programs. Table 1 provides data on R&D funding by agency for FY2019 (actual), FY2020 (enacted), and FY2021 (request). Under the request, eight federal agencies would receive nearly 98% of total federal R&D funding in FY2021: the Department of Defense (DOD), 42.1%; Department of Health and Human Services (HHS), primarily the National Institutes of Health (NIH), 26.6%; Department of Energy (DOE), 11.3%; National Aeronautics and Space Administration (NASA), 9.4%; National Science Foundation (NSF), 4.5%; Department of Agriculture (USDA), 1.9%; Department of Commerce (DOC), 1.1%; and Department of Veterans Affairs (VA), 1.0%. This report provides an analysis of the R&D budget requests for these agencies, as well as for the Department of Homeland Security (DHS), Department of the Interior (DOI), Department of Transportation (DOT), and Environmental Protection Agency (EPA). All but one federal agency would see their R&D funding decrease under the President's FY2021 request compared to their FY2020 enacted level. The only agency that would see an increase in R&D funding in FY2021 relative to the FY2020 level would be the VA (up $38 million, 2.9%). The agencies with the largest R&D funding declines (measured in dollars) in the FY2021 request compared to FY2020 enacted level are DOD (down $4.713 billion), DOE (down $3.168 billion), HHS (down $2.943 billion), NASA (down $723 million), and DOT (down $540 million). See Table 1 . The agencies with the largest percentage declines in R&D funding in the FY2021 request compared to FY2020 enacted level are DOT (down 47.6%), EPA (down 35.4%), DOI (down 25.5%), DOC (down 22.7%), and DOE (down 16.5%). See Table 1 . Federal R&D funding can also be examined by the character of work it supportsâbasic research, applied research, or developmentâand by funding provided for construction of R&D facilities and acquisition of major R&D equipment. (See Table 2 .) President Trump's FY2021 request includes $40.638 billion for basic research, down $2.822 billion (6.5%) from FY2020 enacted level; $38.805 billion for applied research, down $5.125 billion (11.7%); $59.112 billion for development, down $3.466 billion (5.5%); and $3.630 billion for facilities and equipment, down $2.375 billion (39.6%). A primary policy justification for public investments in basic research and for incentives (e.g., tax credits) for the private sector to conduct research is the view, widely held by economists, that the private sector will, left on its own, underinvest in basic research from a societal perspective. The usual argument for this view is that the social returns (i.e., the benefits to society at large) exceed the private returns (i.e., the benefits accruing to the private investor, such as increased revenues or higher stock value). Other factors that may inhibit corporate investment in basic research include long time horizons for achieving commercial applications (diminishing the potential returns due to the time value of money), high levels of technical risk and uncertainty, shareholder demands for shorter-term returns, and asymmetric and imperfect information. The federal government is the nation's largest supporter of basic research, funding 42% of U.S. basic research in 2018 (the most recent year for which comprehensive data are available). Business funded 29% of U.S. basic research in 2018, with state governments, universities, and other nonprofit organizations funding the remaining 30%. For U.S. applied research, business is the primary funder, accounting for an estimated 54% in 2018, while the federal government accounted for an estimated 34%. State governments, universities, and other nonprofit organizations funded the remaining 11%. Business also provides the vast majority of U.S. funding for development. Business accounted for 85% of development funding in 2018, while the federal government provided 13%. State governments, universities, and other nonprofit organizations funded the remaining 2% (see Figure 1 ). Federal R&D funding can also be viewed from the combined perspective of each agency's contribution to basic research, applied research, development, and facilities and equipment. Table 3 lists the three agencies with the most funding in each of these categories as proposed in the President's FY2021 budget. The overall federal R&D budget reflects a wide range of national priorities, including supporting advances in spaceflight, developing new and affordable sources of energy, and understanding and deterring terrorist groups. These priorities and the mission of each individual agency contribute to the composition of that agency's R&D spending (i.e., the allocation of R&D funding among basic research, applied research, development, and facilities and equipment). In the President's FY2021 budget request, the Department of Health and Human Services, primarily NIH, would account for nearly half (47.1%) of all federal funding for basic research. HHS would also be the largest federal funder of applied research, accounting for about 47.3% of all federally funded applied research in the President's FY2021 budget request. DOD would be the primary federal funder of development, accounting for 88.0% of total federal development funding in the President's FY2021 budget request. DOE would be the primary federal funder of facilities and equipment, accounting for 58.7% of total federal facilities and equipment funding in the President's FY2021 budget request. For many years, presidential budgets have reported on multiagency R&D initiatives. Often, they have also provided details of agency funding for these initiatives. Some of these efforts have a statutory basisâfor example, the Networking and Information Technology Research and Development (NITRD) program, the National Nanotechnology Initiative (NNI), and the U.S. Global Change Research Program (USGCRP). These programs generally produce annual budget supplements identifying objectives, activities, funding levels, and other information, usually published shortly after the presidential budget release. Other multiagency R&D initiatives have operated at the discretion of the President, without such a basis, and may be eliminated at the discretion of the President. President Trump's FY2021 budget is largely silent on funding levels for these efforts and whether any or all of the nonstatutory initiatives will continue. Some activities related to these initiatives are discussed in agency budget justifications and may be addressed in the agency analyses later in this report. This section provides available multiagency information on these initiatives and will be updated as additional information becomes available. Established by the High-Performance Computing Act of 1991 ( P.L. 102-194 ), the Networking and Information Technology Research and Development program is the primary mechanism by which the federal government coordinates its unclassified networking and information technology R&D investments in areas such as supercomputing, high-speed networking, cybersecurity, software engineering, and information management. According to NITRD, it coordinates the information technology R&D activities of 24 federal agency members and more than 45 other participating agencies with program interests and activities in IT R&D. NITRD efforts are coordinated by the National Science and Technology Council (NSTC) Subcommittee on Networking and Information Technology Research and Development. P.L. 102-194 , as reauthorized by the American Innovation and Competitiveness Act of 2017 ( P.L. 114-329 ), requires the director of NITRD to prepare an annual report to be delivered to Congress along with the President's budget request. This annual report, often referred to as a budget supplement, is to include, among other things, detailed information on the program's budget for the current and previous fiscal years and the proposed budget for the next fiscal year. The latest annual report was published in September 2019 and related to the FY2020 budget request. President Trump requested $5.506 billion for NITRD research in FY2020, a decrease of $195 million (3.4%) from the estimated FY2019 level (see Table 4 ). For additional information on the NITRD program, see CRS Report RL33586, The Federal Networking and Information Technology Research and Development Program: Background, Funding, and Activities , by Patricia Moloney Figliola. Additional NITRD information also can be obtained at https://www.nitrd.gov . The U.S. Global Change Research Program coordinates and integrates federal research and applications to understand, assess, predict, and respond to human-induced and natural processes of global change. The program seeks to advance global climate change science and to "build a knowledge base that informs human responses to climate and global change through coordinated and integrated Federal programs of research, education, communication, and decision support." In FY2019, 10 departments and agencies received appropriations for their USGCRP participation. USGCRP efforts are coordinated by the NSTC Subcommittee on Global Change Research. Each agency develops and carries out its activities as its contribution to the USGCRP, and funds are appropriated to each agency for those activities; those activities may or may not be identified as associated with the USGCRP in agency budget justifications or other program materials available publicly. Complementing USGCRP activities are many federal climate change or global change-related activities with programmatic missions, not predominantly scientific. These are reported separately in budget justifications. The Global Change Research Act of 1990 (GCRA) ( P.L. 101-606 ) requires each federal agency or department involved in global change research to report annually to Congress on each element of its proposed global change research activities, as well as the portion of its budget request allocated to each element of the program. The President is also required to identify those activities and the annual global change research budget in the President's annual budget request. The President's budget requests for years later than FY2017 do not report these budget data required by the GCRA, although some agencies report their contributions in their budget justifications to Congress. In addition, in the 20 years prior to FY2018, language in appropriations laws required the President to submit a comprehensive report to the appropriations committees "describing in detail all Federal agency funding, domestic and international, for climate change programs, projects, and activities â¦ including an accounting of funding by agencyâ¦." As these are no longer reported by the Office of Management and Budget, Table 5 presents data compiled by CRS from communications with departments and agencies that participated in the USGCRP in FY2018. For additional information on the USGCRP, see CRS Report R43227, Federal Climate Change Funding from FY2008 to FY2014 , by Jane A. Leggett, Richard K. Lattanzio, and Emily Bruner. Additional USGCRP information can be obtained at http://www.globalchange.gov . Launched in FY2001, the National Nanotechnology Initiative is a multiagency R&D initiative to advance understanding and control of matter at the nanoscale, where the physical, chemical, and biological properties of materials differ in fundamental and sometimes useful ways from the properties of individual atoms or bulk matter. In 2003, Congress enacted the 21 st Century Nanotechnology Research and Development Act ( P.L. 108-153 ), providing a legislative foundation for some of the activities of the NNI. NNI efforts are coordinated by the NSTC Subcommittee on Nanoscale Science, Engineering, and Technology (NSET). For FY2020, the President's request included NNI funding for 15 federal departments and independent agencies and commissions with budgets dedicated to nanotechnology R&D. The NSET includes other federal departments and independent agencies and commissions with responsibilities for health, safety, and environmental regulation; trade; education; intellectual property; international relations; and other areas that might affect or be affected by nanotechnology. P.L. 108-153 requires the NSTC to prepare an annual report to be delivered to Congress at the time the President's budget request is sent to Congress. This annual report, often referred to as a budget supplement, is to include detailed information on the program's budget for the current fiscal year and the program's proposed budget for the next fiscal year, as well as additional information and data related to the performance of the program. The latest annual report was published in August 2019 and related to the FY2020 budget request. President Trump requested $1.469 billion for NNI research in FY2020, a decrease of $103 million (6.6%) from the estimated FY2019 level. For additional information on the NNI, see CRS Report RL34401, The National Nanotechnology Initiative: Overview, Reauthorization, and Appropriations Issues , by John F. Sargent Jr. Additional NNI information can be obtained at http://www.nano.gov . The President's FY2021 budget highlights R&D spending in several areas discussed in the following sections. The President's FY2021 budget states the Administration's prioritization for areas of science and technology that it asserts will underpin the Industries of the Future (IotF), among other prioritizations and reallocations in lower priority areas. For 2021, the Administration is prioritizing the science and technology that underpin the Industries of the Future (IotF)âartificial intelligence (AI), quantum information science (QIS), 5G/advanced communications, biotechnology, and advanced manufacturing. Relative to the 2020 President's Budget, this includes major increases in QIS and non-defense AI R&D as part of a commitment to double Federal AI and QIS R&D investments by 2022. R&D investments in AI and QIS, in particular, act as innovation multipliers and employment drivers, not only by promoting S&T progress across many disciplines, but also by helping to build a highly-skilled American workforce. Other IotF areas, such as biotechnology and advanced manufacturing, are poised for potentially transformative advances. Together, IotF investments are vital to the Nation's global competitiveness and the health, prosperity, and security of the American people. On February 11, 2019, President Trump issued Executive Order 13859, "Maintaining American Leadership in Artificial Intelligence," launching the American AI Initiative and later that year defined the effort's priority investment areas in The National Artificial Intelligence Research and Development Strategic Plan: 2019 Update . The FY2021 budget states that AI "is transforming every segment of American life, with applications ranging from medical diagnostics and precision agriculture, to autonomous transportation, job reskilling and upskilling and national defense, and beyond." The FY2021 budget includes increases in the AI R&D budget as part of its efforts to double non-defense AI R&D funding by FY2022. The President's proposed AI R&D funding for FY2021 includes A 76% increase in the AI R&D budget of the National Science Foundation to $868 million over the FY2020 level, for AI-related research and the creation of several National AI Research Institutes, in collaboration with USDA, DHS, DOT, and VA. The institutes are to support multisector, multidisciplinary research and workforce efforts among academia, industry, federal agencies, and nonprofits. An additional $100 million for the USDA Agriculture and Food Research Initiative (AFRI) for AI and machine learning research to promote advanced manufacturing in the food and agricultural sciences, as well as to continue efforts in robotics and the application of big data to precision agriculture. $125 million for DOE's Office of Science, a $54 million increase over the FY2020 request. $50 million for NIH research on chronic diseases using AI and related approaches. $459 million for DARPA AI R&D, an increase of $50 million from the FY2020 request. $290 million for DOD's Joint AI Center, up from $242 million in FY2020. The FY2021 budget seeks an increase of more than 50% for federal quantum information science (QIS) funding over the FY2020 budget as part of the Administration's goal of doubling funding for QIS by FY2022. The President's proposed QIS R&D funding for FY2021 includes $230 million for NSF to support the National Quantum Initiative, $120 million above the FY2020 level. $237 million for the DOE Office of Science, an increase of approximately $75 million, for QIS work at the national laboratories and in academia and industry. $25 million for the DOE Office of Science to support early stage research for a quantum internet. Additionally, the budget provides funding for NIST work in QIS standards and engineering efforts in quantum systems; funding for the defense and intelligence community for QIS science and technology, new applications, and industrial engagement; and initial funding for NASA to explore the potential for a space-based quantum entanglement experiment. The President's budget also includes an additional $50 million for NSF, compared to the 2020 budget, for education and workforce development for AI and QIS, with focused outreach efforts to community colleges, Historically Black Colleges and Universities (HBCUs), and Minority Serving Institutions (MSIs). The President's FY2021 budget also highlights investments in national security-related R&D, including more than $59 billion in research, engineering, and prototyping activities in FY2021 to enable advanced military capabilities, including work in "offensive and defensive hypersonic weapons capabilities, resilient national security space systems, and modernized and flexible strategic and nonstrategic nuclear deterrent capabilities." The FY2021 budget request for Department of Homeland Security R&D includes $83 million for detection and defense against radiological, nuclear, chemical, and biological threats; $44 million for improving resilience to natural disasters and physical threats, for first responder technologies and public safety, and for cross-border threat screening and supply chain defense; and $38 million for cybersecurity. The mission of the Department of Defense is to provide "the military forces needed to deter war and ensure our nation's security." Congress supports research and development activities at DOD primarily through the department's Research, Development, Test, and Evaluation (RDT&E) funding. These funds support the development of the nation's future military hardware and software and the science and technology base upon which those products rely. Most of what DOD spends on RDT&E is appropriated in Title IV of the annual defense appropriations bill. (See Table 7 .) Title IV RDT&E funds support activities such as R&D performed by academic institutions, DOD laboratories, and companies, as well as test and evaluation activities at specialized DOD facilities, among other things. However, RDT&E funds are also appropriated in other parts of the bill. For example, RDT&E funds are appropriated as part of the Defense Health Program, the Chemical Agents and Munitions Destruction Program, and the National Defense Sealift Fund. The Defense Health Program (DHP) supports the delivery of health care to DOD personnel and their families. DHP funds (including the RDT&E funds) are requested through the Defense-wide Operations and Maintenance appropriations request. The program's RDT&E funds support congressionally directed research on breast, prostate, and ovarian cancer; traumatic brain injuries; orthotics and prosthetics; and other medical conditions. Congress appropriates funds for this program in Title VI (Other Department of Defense Programs) of the defense appropriations bill. The Chemical Agents and Munitions Destruction Program supports activities to destroy the U.S. inventory of lethal chemical agents and munitions to avoid future risks and costs associated with storage. Funds for this program are requested through the Defense-wide Procurement appropriations request. Congress appropriates funds for this program also in Title VI. The National Defense Sealift Fund supports the procurement, operation and maintenance, and research and development associated with the nation's naval reserve fleet and supports a U.S. flagged merchant fleet that can serve in time of need. In some fiscal years, RDT&E funding for this effort is requested in the Navy's Procurement request and appropriated in Title V (Revolving and Management Funds) of the appropriations bill. RDT&E funds also have been requested and appropriated as part of DOD's separate funding to support efforts in what the George W. Bush Administration termed the Global War on Terror (GWOT) and what the Obama and Trump Administrations have referred to as Overseas Contingency Operations (OCO). In appropriations bills, the term Overseas Contingency Operations/Global War on Terror (OCO/GWOT) has been used; President Trump's FY2021 budget uses the term Overseas Contingency Operations. Typically, the RDT&E funds appropriated for OCO activities go to specified Program Elements (PEs) in Title IV. According to the Comptroller of the Department of Defense, the FY2021 OCO request is divided into two requirement categoriesâdirect and enduring war, and OCO for base requirements. For purposes of this report, these categories of OCO funding requests are reported collectively. In addition, OCO/GWOT-related requests/appropriations have included money for a number of transfer funds. In the past, these have included the Iraqi Freedom Fund (IFF), the Iraqi Security Forces Fund, the Afghanistan Security Forces Fund, and the Pakistan Counterinsurgency Capability Fund. Congress typically has made a single appropriation into each such fund and authorized the Secretary of Defense to make transfers to other accounts, including RDT&E, at his discretion. These transfers are eventually reflected in Title IV prior-year funding figures. For FY2021, the Trump Administration is requesting $106.555 billion for DOD's Title IV RDT&E PEs (base plus OCO), $1.159 billion (1.1%) above the enacted FY2020 level. (See Table 7 .) In addition, the FY2021 request includes $562.5 million in RDT&E through the Defense Health Program (DHP; down $1.744 billion, 75.6% from FY2020), $782.2 million in RDT&E through the Chemical Agents and Munitions Destruction program (down $93.7 million, 10.7% from FY2020), and $1.1 million for the Inspector General for RDT&E-related activities (down $1.9 million, 63.0% from FY2020). The FY2021 budget includes no RDT&E funding via the National Defense Sealift Fund, the same as the FY2020 enacted level. RDT&E funding can be analyzed in different ways. RDT&E funding can be characterized organizationally. Each military department requests and receives its own RDT&E funding. So, too, do various DOD agencies (e.g., the Missile Defense Agency and the Defense Advanced Research Projects Agency), collectively aggregated within the Defense-Wide account. RDT&E funding also can be characterized by budget activity (i.e., the type of RDT&E supported). Those budget activities designated as 6.1, 6.2, and 6.3 (basic research, applied research, and advanced technology development, respectively) constitute what is called DOD's Science and Technology (S&T) program and represent the more research-oriented part of the RDT&E program. Budget activities 6.4 and 6.5 focus on the development of specific weapon systems or components for which an operational need has been determined and an acquisition program established. Budget activity 6.6 provides management support, including support for test and evaluation facilities. Budget activity 6.7 supports the development of system improvements in existing operational systems. Budget activity 6.8 was added in the FY2021 budget and supports software and digital technology pilot programs. Many congressional policymakers are particularly interested in DOD S&T program funding, since these funds support the development of new technologies and the science that underlies them. Some in the defense community see ensuring adequate support for S&T activities as imperative to maintaining U.S. military superiority into the future. The knowledge generated at this stage of development may also contribute to advances in commercial technologies. The FY2021 request for Title IV S&T funding (base plus OCO) is $14.070 billion, $1.991 billion (12.4%) below the FY2020 enacted level. Within the S&T program, basic research (6.1) receives special attention, particularly by the nation's universities, as over half of DOD's basic research budget is spent at universities. The Trump Administration is requesting $2.319 billion for DOD basic research for FY2021, $284.2 million (10.9%) below the FY2020 enacted level. While DOD is not the largest federal funder of basic research, it is a substantial source of federal funds for university R&D in certain fields, such as aerospace, aeronautical, and astronautical engineering (60%); electrical, electronic, and communications engineering (58%); industrial and manufacturing engineering (48%); mechanical engineering (46%); computer and information sciences (44%); metallurgical and materials engineering (39%); and materials science (33%). The mission of the Department of Health and Human Services (HHS) is "to enhance and protect the health and well-being of all Americans ... by providing for effective health and human services and fostering advances in medicine, public health, and social services." This section focuses on HHS research and development funded through the National Institutes of Health (NIH), an HHS agency that accounts for nearly 97% of total HHS R&D funding. Other HHS agencies that support R&D include the Centers for Disease Control and Prevention (CDC), Centers for Medicare and Medicaid Services (CMS), Food and Drug Administration (FDA), Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA), and Administration for Children and Families (ACF); additional R&D funding is attributed to departmental management. NIH is the primary agency of the federal government charged with performing and supporting biomedical and behavioral research. It also has major roles in training biomedical researchers and disseminating health information. The NIH mission is "to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability." The agency consists of the NIH Office of the Director (OD) and 27 institutes and centers (ICs). Each IC plans and manages its own research programs in coordination with OD. As shown in Table 8 , separate appropriations are provided to 24 of the 27 ICs, as well as to OD, the Innovation Account (established by the 21 st Century Cures Act in 2016, P.L. 114-255 ), and an intramural Buildings and Facilities account. The other three centers, which perform centralized support services, are funded through transfers from the other ICs. According to NIH, about 10% of the NIH budget supports intramural research projects conducted by the nearly 6,000 NIH federal scientists, most of whom are located on the NIH campus in Bethesda, MD. All research ICs have an intramural research program of varying sizes. More than 80% of NIH's budget goes to the extramural research community in the form of grants, contracts, and other awards. This funding supports research performed by more than 300,000 nonfederal scientists and technical personnel who work at more than 2,500 universities, hospitals, medical schools, and other research institutions. Funding for NIH comes primarily from the annual Labor, HHS, and Education (LHHS) appropriations act, with an additional amount for Superfund-related activities from the Interior/Environment appropriations act. Those two appropriations acts provide NIH's discretionary budget authority. In addition, NIH received mandatory funding of $150 million annually until FY2019 provided in the Public Health Service Act (PHSA), Section 330B, for a special program on type 1 diabetes research. A temporary funding extension has been enacted for FY2020, and under current law, no new funding will be available for this program after May 22, 2020. Some funding is also pursuant to the "PHS Evaluation Tap" transfer authority, under Section 241 of the PHS Act (42 U.S.C. Â§238j). This provision allows the Secretary of HHS, with the approval of appropriators, to redistribute a portion of eligible PHS agency appropriations across HHS for program evaluation purposes. Although the PHS Act limits the tap to no more than 1% of eligible appropriations, in recent years, annual LHHS appropriations acts have specified a higher amount (2.5% in FY2020, P.L. 116-94 ) and have typically directed specific amounts of funding from the tap for transfer to a number of HHS programs. The assessment has the effect of redistributing appropriated funds for specific purposes among PHS and other HHS agencies. NIH, with the largest budget among the PHS agencies, has historically been the largest "donor" of program evaluation funds; until recently, it had been a relatively minor recipient. Provisions in recent LHHS appropriations acts have directed specific tap transfers to NIH, making NIH a net recipient of tap funds. President Trump's FY2021 budget request would provide NIH with a total program level of $38.694 billion, a decrease of $2.992 billion (-7.2%) from FY2020 enacted levels. The proposed FY2020 program level would be made up of $37.630 billion in LHHS budget authority, $741 million pursuant to the PHS Evaluation Tap authority, $74 million for the Superfund Research Program in Interior/Environment appropriations, and $150 million in proposed annual funding for the mandatory type 1 diabetes program. Under the President's FY2021 request, all existing IC accounts would receive a decrease compared to FY2020 enacted levels (see Table 8 ). The Building and Facilities account would receive an increase in terms of LHHS budget authority, from $200 million in FY2020 to $300 million in FY2021. In addition, the full amount ($404 million) authorized by the 21 st Century Cures Act for FY2021 ( P.L. 114-255 ; see text box ) would be appropriated to the Innovation Account. Additionally, the FY2021 budget request proposes consolidating the Agency for Healthcare Research and Quality (AHRQ) into NIH, forming a 28 th ICâthe National Institute for Research on Safety and Quality (NIRSQ). The creation of a new NIH institute would require amendments to the PHSA, especially Section 401(d), which specifies that "[i]n the National Institutes of Health, the number of national research institutes and national centers may not exceed a total of 27." Under the FY2021 request, NISRQ would receive a total appropriation of $355.1 million, including $256.7 million in discretionary LHHS budget authority and $98.5 million in mandatory appropriations from the Patient-Centered Outcomes Research Trust Fund (PCORTF) in Social Security Act Section 1181. Congress did not adopt the Administration's similar proposals to consolidate AHRQ into NIH as NIRSQ in FY2018, FY2019, or FY2020. Additionally, the budget request proposes select specified FY2021 funding levels for programs and activities within and across the NIH accounts based on the Administration's research priorities. For instance, for FY2021, the Administration's budget proposes specific funding levels for the opioid and methamphetamine epidemic ($1.4 billion across the NIH ICs), a childhood cancer data initiative ($50 million), influenza research ($423 million), and tick-borne diseases research ($115 million), among others. If adopted, these funding levels would likely be specified in report and/or explanatory statement language accompanying LHHS appropriations bills. For the most part, Congress does not specify NIH funding for particular diseases or areas of research, instead allowing the ICs to award funding on a competitive basis through various funding mechanisms intended to balance scientific opportunity with health priorities. The Department of Energy was established in 1977 by the Department of Energy Organization Act ( P.L. 95-91 ), which combined energy-related programs from a variety of agencies with defense-related nuclear programs that dated back to the Manhattan Project. Today, DOE conducts basic scientific research in fields ranging from nuclear physics to the biological and environmental sciences; basic and applied R&D relating to energy production and use; and R&D on nuclear weapons, nuclear nonproliferation, and defense nuclear reactors. The department has a system of 17 national laboratories around the country, mostly operated by contractors, that together account for about 40% of all DOE expenditures. The Administration's FY2021 budget request for DOE includes about $13.853 billion for R&D and related activities, including programs in three broad categories: science, national security, and energy. This request is about 19.1% less than the comparable enacted FY2020 amount of $17.124 billion. (See Table 9 for details.) The request for the DOE Office of Science is $5.838 billion, a decrease of 16.6% from the FY2020 appropriation of $7.000 billion. Funding would decrease for five of the office's six major research programs. In the largest program, Basic Energy Sciences, almost two-thirds of the proposed 16.6% decrease would result from spending less on facility construction. Most of the remainder would result from spending less on existing scientific user facilities, in some cases by reducing hours of operation. Funding for Biological and Environmental Research would decrease by 31.1%, with reductions concentrated in the Earth and Environmental Systems Sciences subprogram as proposed in other recent Administration budgets. Funding for Fusion Energy Sciences would decrease by 36.6%. Within Fusion Energy Sciences, the U.S. contribution to construction of the International Thermonuclear Experimental Reactor (ITER), a fusion energy demonstration and research facility in France, would be $107 million (down from $242 million in FY2020). The one major research program receiving an increase would be Advanced Scientific Computing Research (up 0.8%). Within Advanced Scientific Computing Research, an increase of $109 million for research would be partly offset by a decrease of $81 million for facilities; the Office of Science Exascale Computing Project would receive $169 million, down from $189 million in FY2020. The request for DOE national security R&D is $5.066 billion, an increase of 6.3% from $4.765 billion in FY2020. In Weapons Activities, the request for Stockpile Research, Technology, and Engineering would be an increase of 9.0% above the comparable FY2020 amount. The bulk of the increase would be for Assessment Science ($773 million, up from $595 million in FY2020) and Weapon Technology and Manufacturing Maturation ($298 million, up from $222 million in FY2020). A proposed increase of 7.2% for R&D in the Defense Nuclear Nonproliferation account reflects $40 million requested for a program in National Technical Nuclear Forensics R&D, formerly funded in DHS. The request for DOE energy R&D is $2.949 billion, a decrease of 45.0% from $5.360 billion in FY2020. Many of the proposed reductions in this category are similar to the Administration's FY2019 and FY2020 budget proposals. Funding for energy efficiency and renewable energy R&D would decrease by 70.1%, with reductions in all major research areas and a shift in emphasis toward early-stage R&D rather than later-stage development and deployment. In the Fossil Energy R&D account, an increase of $172 million for Advanced Energy Systems would be largely offset by decreases for carbon capture, utilization, and storage ($123 million, down from $218 million in FY2020), natural gas technologies ($15 million, down from $51 million), and oil technologies ($17 million, down from $46 million). The request for nuclear fuel cycle R&D is $187 million (down from $305 million), and nuclear energy as a whole would decrease by 20.1%, with no funding requested for the Integrated University Program ($5 million in FY2020) or the Supercritical Transformational Electric Power (STEP) R&D initiative ($5 million in FY2020). The Advanced Research Projects Agency-Energy (ARPA-E), which is intended to advance high-impact energy technologies that have too much technical and financial uncertainty to attract near-term private-sector investment, would be terminated. The National Aeronautics and Space Administration (NASA) was created in 1958 by the National Aeronautics and Space Act (P.L. 85-568) to conduct civilian space and aeronautics activities. NASA has research programs in planetary science, Earth science, heliophysics, astrophysics, and aeronautics, as well as development programs for future human spacecraft and for multipurpose space technology such as advanced propulsion systems. In addition, NASA operates the International Space Station (ISS) as a facility for R&D and other purposes. The Administration has requested about $22.243 billion for NASA R&D in FY2021. This would be 14.4% more than the FY2020 level of about $19.439 billion. For a breakdown of these amounts, see Table 10 . NASA R&D funding comes through five accounts: Science; Aeronautics; Space Technology (called Exploration Technology in the Administration's budget request); Exploration (Deep Space Exploration Systems in the request); and the ISS, Commercial Crew, and Commercial Low Earth Orbit (LEO) Development portions of Space Operations (called LEO and Spaceflight Operations in the request). The OMB figures presented in Table 1 indicate a substantially smaller amount for NASA R&D than the figures presented in this section, and a decrease in the FY2021 request relative to FY2020 rather than an increase. The main reason for this appears to be that OMB treats only about half of the Exploration account as R&D (somewhat more than half in FY2020, somewhat less than half in FY2021). As systems being developed under that account move from R&D to testing and ultimately operations, the share of the account spent on R&D may decrease. In order to allow consistent tracking as Congress acts on FY2021 appropriations legislation, this section treats the entirety of the Exploration account as R&D. The FY2021 request for Science is $6.307 billion, a decrease of 11.7% from FY2020. Within this total, funding for Earth Science would decrease by $204 million (10.4%) and funding for Astrophysics would decrease by $475 million (36.4%). In Earth Science, the Administration proposes to terminate the Pre-Aerosol, Clouds, and Ocean Ecosystem (PACE) and Climate Absolute Radiance and Refractivity Observatory (CLARREO) Pathfinder missions ($131 million and $26 million respectively in FY2020). In Astrophysics, it proposes to terminate the Wide Field Infrared Space Telescope (WFIRST) and Stratospheric Observatory for Infrared Astronomy (SOFIA) missions ($511 million and $85 million in FY2020). PACE and CLARREO Pathfinder were also proposed for termination in the FY2018 through FY2020 budgets, and WFIRST was also proposed for termination in the FY2019 and FY2020 budgets, but in each case they were funded by Congress. The Planetary Science request includes $404 million (down from $593 million in FY2020) for a mission to orbit Jupiter's moon Europa. Despite direction otherwise in the FY2020 explanatory statement, the Europa mission would be launched on a commercial rocket and would not include a lander. The FY2021 request for Aeronautics is $819 million, an increase of 4.5% from $784 million in FY2020. As projected in prior budgets, the request includes $79 million for the Low Boom Flight Demonstrator program, intended to demonstrate quiet supersonic flight. The FY2021 request for Exploration Technology (currently Space Technology) is $1.578 billion, an increase of 43.5% from FY2020. The combined RESTORE-L/SPIDER mission to demonstrate in-space satellite servicing and robotic manufacturing would receive $134 million (down from $227 million in FY2020). A newly integrated Space Nuclear Technologies portfolio would receive $100 million for development of space nuclear power and propulsion technologies. The budget justification emphasizes Exploration Technology's support of NASA's Artemis human exploration initiative and its plans for a human lunar landing in 2024. In contrast, FY2020 congressional report language emphasized "broad technology development goals â¦ independent of mission-specific needs" ( H.Rept. 116-101 ) and technologies that "can serve all NASA mission directorates and are not solely focused on enabling human spaceflight" ( S.Rept. 116-127 ). The FY2021 request for Deep Space Exploration Systems (currently Exploration) is $8.762 billion, an increase of 45.6% from FY2020. Within this account, the request for Exploration Systems Development includes $1.401 billion for the Orion crew capsule (down from $1.407 billion in FY2020) and $2.257 billion for the Space Launch System heavy-lift rocket (SLS, down from $2.586 billion in FY2020). The proposed 228.9% increase for Exploration R&D reflects a request for $3.370 billion for development of a human lunar landing system. Exploration R&D funding would also include $739 million (up from $450 million in FY2020) for development of the Gateway lunar-orbiting platform, intended to support human and robotic missions to the lunar surface. In the LEO and Spaceflight Operations account (currently Space Operations), the request includes $1.401 billion for the ISS; $100 million for the Commercial Crew program (down from $102 million in FY2020); and $150 million for Commercial LEO Development (up from $15 million in FY2020). Commercial crew activities are transitioning from development to operations (which is funded separately); following additional test flights to obtain safety certification from NASA, the first post-certification crewed commercial flight to the ISS is expected during 2020. The Commercial LEO Development program, intended to stimulate a commercial space economy in low Earth orbit, was initiated in the FY2019 budget. The Administration has requested $150 million for it each year since then; Congress has so far appropriated a total of $55 million. The National Science Foundation supports basic research and education in the nonmedical sciences and engineering. Congress established the foundation as an independent federal agency in 1950 and directed it to "promote the progress of science; to advance the national health, prosperity, and welfare; to secure the national defense; and for other purposes." The NSF is a primary source of federal support for U.S. university research, especially in computer science, biology, mathematics and the social and psychological sciences. It is also responsible for significant shares of the federal science, technology, engineering, and mathematics (STEM) education program portfolio and federal STEM student aid and support. NSF has six appropriations accounts: Research and Related Activities (RRA, the main research account), Education and Human Resources (EHR, the main education account), Major Research Equipment and Facilities Construction (MREFC), Agency Operations and Award Management (AOAM), the National Science Board (NSB), and the Office of Inspector General (OIG). Appropriations are generally provided at the account level, while program-specific direction may be included in appropriations acts, or accompanying conference reports or explanatory statements. Funding for R&D is included in the RRA, EHR, and MREFC accounts. (The RRA and EHR accounts also include non-R&D funding.) Together, these three accounts comprise over 95% of the total requested funding for NSF. Actual R&D obligations for each account are known after NSF allocates funding appropriations to specific activities and reports those figures. The budget request specifies R&D funding for the conduct of research, including basic and applied research, and for physical assets, including R&D facilities and major equipment. Funding amounts for FY2019 actual and FY2021 requested levels are reported by account, including amounts for R&D conduct and physical assets where applicable, in Table 11 . Funding for NSF for FY2020 was enacted on December 20, 2019. Funding details below the account level were not available at the time the FY2021 budget request was prepared. Therefore, at the account level, the FY2021 request amounts are compared to the FY2020 enacted amounts, as well as to the FY2019 actual amounts in this analysis; below the account level and for R&D totals, the FY2021 request amounts are compared to FY2019 actual amounts. This section will be updated when FY2020 R&D breakouts and subaccount funding amounts are available for comparison. FY2019 actual, FY2020 enacted, and FY2021 requested amounts are reported by account in Table 11 ; funding for R&D conduct and facilities and equipment is included for FY2021 requested and FY2019 actual amounts. Overall . The Administration is requesting $7.741 billion for the NSF in FY2021, $537 million (6.5%) less than the FY2020 enacted amount, and $409 million (5.0%) less than the FY2019 actual amount. The request would decrease budget authority in all three of the R&D accounts relative to the FY2020 enacted level: RRA by $524 million (7.8%), EHR by $9.1 million (1.0%), and MREFC by $13.5 million (5.5%). Overall, NSF estimates that, under the FY2021 request, agency-wide funding rates (i.e., the percentage of submitted proposals that are successfully awarded funding) would decrease slightly from 27% to 25%, with 500 fewer new competitive awards, compared to FY2019. As a proportion of NSF's total funding, R&D activities account for approximately 80%. For FY2021, $6.33 billion is requested for R&D activities, a 4.8% decrease from FY2019 actual funding for R&D of $6.65 billion. The total request includes $5.80 billion (92%) for the conduct of R&D, and $523 million (8%) for R&D facilities and major equipment. Of funding requested for the conduct of R&D, 86% is requested for basic research, and 14% for applied research. Overall funding for R&D facilities and major equipment supports not only the construction and acquisition phases, funded through MREFC ($230 million requested), but also the planning, design, and postconstruction operations and maintenance, funded through RRA ($293 million requested). Research . The Administration seeks $6.21 billion for RRA in FY2021, a $524 million (7.8%) decrease compared to the FY2020 enacted funding, and a $365 million (5.6%) decrease compared to FY2019 actual funding. Compared to the FY2019 actual levels, the FY2021 request includes decreases for 8 of the 10 RRA subaccounts. The largest percentage decrease would go to the Office of Polar Programs (14.1%, down $69 million). The Computer and Information Science and Engineering (CISE) subaccount would receive the largest dollar increase (7.8%, up $77 million). The FY2021 request also includes $164 million for the RRA Established Program to Stimulate Competitive Research (EPSCoR) program, a $12 million (6.8%) decrease compared to FY2019 actual funding. Within the RRA account, the FY2021 request includes $5.61 billion for R&D, a decrease of $284 million (4.8%) compared to the FY2019 actual amount. Of this amount, the majority ($5.32 billion, 95%) is requested for the conduct of research, including $4.85 billion for basic research and $469 million for applied research. Education . The FY2021 request for the EHR account is $931 million, $9.1 million (1.0%) less than the FY2020 enacted amount and $3.6 million (0.4%) less than the FY2019 actual level. By program division, the Division of Graduate Education would receive an increase of $28.7 million (11.3%) over the FY2019 actual level. The Divisions of Research on Learning in Formal and Informal Settings, and Undergraduate Education would receive decreases of 2.1% ($224 million requested), and 10.7% ($237 million requested), respectively. The Division on Human Resource Development would receive approximately the same amount of funding ($189 million requested). EHR programs of particular interest to congressional policymakers include the Graduate Research Fellowship Program (GRFP) and National Research Traineeship (NRT) programs. The FY2021 request for GRFP is $275 million, a reduction of $9.27 million (3.3%) from the FY2019 actual level. The FY2021 request for NRT is $61.9 million, a $7.78 million increase (14.4%) from FY2019. Within EHR, requested funding for R&D is $485 million, which is $17.9 million (3.8%) more than the FY2019 actual funding amount and accounts for approximately 7.7% of the agency's total R&D request. All of the requested funding would support the conduct of R&D, including $167 million for basic research and $318 million for applied research. Construction . The MREFC account supports large construction projects and scientific instruments, with all of the funding supporting R&D facilities. The construction phases of such large-scale projects tend to span multiple years; therefore, NSF provides out-year estimates of funding for major facilities for the duration of the anticipated timeline, which are updated annually. This section of the analysis includes comparisons to FY2020 estimated funding, based on these projections. The Administration is seeking $230 million for MREFC in FY2021, $13.5 million (5.5%) less than the FY2020 enacted amount, and $55.5 million (19.5%) less than the FY2019 actual amount. Requested MREFC funding would support continued construction of the Vera C. Rubin Observatory ($40.8 million requested, down 12.1% from the FY2020 estimate)âpreviously called the Large Synoptic Survey Telescope (LSST)âand the Antarctic Infrastructure Modernization for Science project (AIMS, $90.0 million requested, down 8.1% from FY2020 estimate). The request includes $33.0 million for upgrades to the Large Hadron Collider in Switzerland, which would represent the second year of a five-year project. Additionally, $65.0 million is requested for Mid-scale Research Infrastructure projects (those projects with funding amounts in the $20 million to $70 million range); this was a new funding line-item in the MREFC account as of FY2020, meant to manage support for upgrades to major facilities and stand-alone projects in this range as a portfolio. Other initiatives . The FY2021 NSF budget request includes funding for multiple agency-wide investments, including the Big Ideas and Convergence Accelerator, as well as three multiagency initiatives. This funding is included in multiple NSF appropriations accounts, and R&D amounts are not separately provided. The Big Ideas, which include six Research and three Enabling Big Ideas, first proposed in 2016, "endeavor to break down the silos of conventional scientific research â¦ to define and push the frontiers of global science and engineering leadership and to invest in fundamental research." Requested funding amounts for each of the Big Ideas compared to the FY2019 actual amounts include the following: Harnessing the Data Revolution for 21 st -Century Science and Engineering (HDR): $45 million requested, up $15 million (50%) from FY2019. The Future of Work at the Human Technology Frontier (FW-HTF): $45 million requested, up $15 million (50%) from FY2019. The Quantum Leap (QL): Leading the Next Quantum Revolution: $50 million requested, up $20 million (67%) from FY2019. Navigating the New Arctic (NNA): $30 million requested, equal to FY2019. Understanding the Rules of Life (URoL): Predicting Phenotype: $30 million requested, equal to FY2019. Windows on the Universe (WoU): The Era of Multi-Messenger Astrophysics: $30 million requested, equal to FY2019. Inclusion across the Nation of Communities of Learners of Underrepresented Discoverers in Engineering and Science (NSF INCLUDES): $18.9 million requested, down $1.3 million (6.3%) from FY2019. Growing Convergence Research at NSF (GCR): $15.2 million requested, down $0.6 million (3.8%) from FY2019. Mid-Scale Research Infrastructure: $97.7 million requested, up $37.6 million (62.7%) from FY2019. The Convergence Accelerator (CA) is an organizational framework that stands separately from the NSF research directorates, with its own budget, staff, and initiatives. Each CA research track will be a time-limited entity focused on specific research topics and themes. Therefore, CA research tracks will evolve over time and will be informed by external stakeholder input. The CA will reward high-risk, innovative thinking by multidisciplinary teams of researchers who want to accelerate discovery and innovation. The CA is a way of achieving rapid lab-to-market or research outcomes. The initial CA research tracks have focused on a subset of the Big Ideas, though the CA investments "are distinguished from the corresponding Big Ideas by the nature of the research, the time scale of the activities supported, and the more hands-on, agile approach to project management and support that is envisioned [by the CA program]." NSF has requested $70 million for the CA in FY2021, which is $28.6 million more than the FY2019 actual amount. The budget request states that NSF anticipates financial contributions from external partners to begin in FY2021 (amount unspecified). The budget request also includes three multi-agency initiatives. The National Nanotechnology Initiative would receive $454 million, $67.2 million (12.9%) less than in FY2019. The Networking and Information Technology Research and Development program would receive $1.57 billion, an increase of $151 million (10.7%). The U.S. Global Change Research Program would receive $217 million, $24 million (9.8%) less than in FY2019. The U.S. Department of Agriculture (USDA) was created in 1862 to support agricultural research in an expanding, agriculturally dependent country. Today, USDA conducts intramural research at federal facilities with federally employed scientists and supports extramural research at universities and other facilities through competitive grants and capacity (formula-based) funding. The breadth of contemporary USDA research spans traditional agricultural production practices, organic and sustainable agriculture, bioenergy, nutritional needs and food composition, food safety, animal and plant health, pest and disease management, economic decisionmaking, and other social sciences affecting consumers, farmers, and rural communities. The four agencies of USDA's Research, Education, and Economics (REE) mission area carry out the Department's research and education activities. These agencies are the Agricultural Research Service (ARS), the principal intramural research agency; the National Institute of Food and Agriculture (NIFA), the principal extramural research agency; the National Agricultural Statistics Service (NASS), which undertakes a variety of surveys to capture relevant data; and the Economic Research Service (ERS), which applies economic analysis to a wide range of topics related to food and agriculture. In addition to the four REE agencies, the Office of the Chief Scientist (OCS), a staff office within the Office of the Under Secretary of REE, coordinates science activities across the department. The FY2020 enacted appropriations ( P.L. 116-94 ) provide a total of $3,399.5 million in discretionary spending for the REE agencies. The Administration is requesting a total of $3,248.3 million for these agencies in FY2021, a 4.4% reduction ($151.2 million). The Administration request reflects a reduction of $189.2 million for ARS. The overall reduction also includes proposed decreases in certain activities at NIFA, NASS, and ERS. The Administration is requesting increases for NIFA competitive research grants ($175.0 million) and NASS's Census of Agriculture ($1.0 million). USDA's FY2020 enacted discretionary appropriations and the Administration's FY2021 request for the four research agencies and OCS are discussed below, with funding amounts presented in Table 12 . In addition to discretionary appropriations, agricultural research is funded by state matching contributions and private donations or grants, as well as certain mandatory funding authorized by the 2018 farm bill ( P.L. 115-334 ). The Agricultural Research Service is USDA's in-house basic and applied research agency, and it has major responsibilities for conducting and leading the national agricultural research effort. ARS operates approximately 90 laboratories in the United States and abroad, with about 5,000 permanent employees, including approximately 2,000 research scientists. ARS laboratories focus on efficient food and fiber production, development of new products and uses for agricultural commodities, development of effective controls for pest management, and support of USDA regulatory and technical assistance programs. ARS also operates the National Agricultural Library (NAL). NAL is the world's largest agricultural research library, and is a primary information repository for food, agriculture, and natural resource sciences. For FY2020, P.L. 116-94 provides $1,414.4 million for ARS salaries and expenses, and $192.7 million for buildings and facilities. For FY2021, the Administration is requesting $1,367.9 million for ARS salaries and expenses, a decrease of $46.5 million (3.3%) from the FY2020 appropriation. For FY2021, the request for the buildings and facilities account is $50.0 million, a reduction of $142.7 million (74.1%), from the FY2020 appropriation, largely due to eliminating funds for ARS co-located facilities (as opposed to those facilities owned and operated by ARS). The FY2020 explanatory statement accompanying the FY2020 appropriations bill ( H.R. 1865 ) does not support the Administration's request to terminate or redirect various ARS research programs, and it encourages ARS to fill numerous vacant positions. ARS has been coordinating with the Department of Homeland Security on the new National Bio and Agro-Defense Facility (NBAF), which DHS is constructing to replace the outdated Plum Island Animal Disease Center (PIADC). In January 2019, USDA and DHS signed a Memorandum of Agreement to govern the transition of NBAF from DHS to USDA, with ownership to transfer upon its completion and commissioning in December 2022 . The FY2020 appropriations for ARS provide $13.1 million to address one-time costs associated with the transfer of operations from PIADC to NBAF, in addition to $66.0 million for operations and maintenance, as reported by USDA. For FY2021, the Administration is requesting a total of $81.3 million within ARS Salaries and Expenses for NBAF operations, and maintenance, a $15.3 million increase from the FY2020 appropriation. The FY2021 budget request for ARS also includes an $8 million increase for NBAF research under ARS's livestock research program. The National Institute of Food and Agriculture is USDA's principal extramural research agency. It provides federal funding for research, education, and extension projects conducted in partnership with land-grant colleges and universities (LGUs), State Agricultural Experiment Stations, the Cooperative Extension System, other research and education institutions, private organizations, and individuals. NIFA partnerships include the three types of LGUsâ1862 (original) Institutions, 1890 (historically black) Institutions, and 1994 (tribal) Institutionsâas well as other higher education institutions. Federal funds awarded through NIFA capacity (formula-based) and competitive grants enhance research capacity at these institutions. NIFA headquarters are located in Washington, DC. In October 2019, USDA relocated the majority of NIFA staff positions to Kansas City, MO. For FY2020, P.L. 116-94 provides $1,527.4 million in discretionary funds for NIFA activities. For FY2021, the Administration requests $1,590.8 million, an increase of $63.4 million (4.2%). Research and Education. Hatch Act and Evans-Allen Act funds support capacity grants for research and education activities at 1862 and 1890 Institutions, respectively. For Hatch Act programs, the enacted FY2020 bill provides $259.0 million, and the Administration is requesting $243.2 million for FY2021, a 6.1% reduction. For Evans-Allen programs, the FY2020 appropriation provides $67.0 million, and for FY2021 the Administration is requesting $53.8 million, a 19.7% reduction. For competitive research grants at 1994 Institutions, the FY2020 appropriation provides $3.8 million, and the Administration requests the same funding level for FY2021. For education grant programs for the insular areas and for Alaska native and native Hawaiian-serving institutions, the FY2020 appropriation provides $2.0 million and $3.2 million, respectively. For FY2021, the Administration requests $0 for both programs, and in lieu of these it proposes to create a new, combined program with requested funding of $5.0 million. The McIntire-Stennis program provides capacity funds for forestry research. For FY2020, P.L. 116-94 provides $36.0 million, and for FY2021 the Administration is requesting $28.9 million, a 20% reduction. The Agriculture and Food Research Initiative (AFRI) is USDA's flagship competitive research grants program, and currently represents about 31% of the total of NIFA's discretionary budget. The FY2020 enacted bill provides $425.0 million for AFRI, and the Administration is requesting $600.0 million for FY2021, a 41.2% increase. NIFA also funds the Sustainable Agriculture Research and Education (SARE) program. For FY2020, P.L. 116-94 provides $37.0 million for SARE, and the Administration requests the same level of funding for FY2021. Extension. Smith-Lever Act 3(b) and 3(c) programs provide capacity grants to 1862 Institutions to support cooperative extension. The FY2020 enacted appropriation provides $315.0 million for these programs, and the Administration requests $299.4 million for them in FY2021, a reduction of 4.9%. Smith-Lever 3(d) programs provide competitive grants to 1862, 1890, and 1994 Institutions to support cooperative extension. These programs include grants for food and nutrition education; new technologies for agricultural extension; federally recognized tribes; children, youth, and families at risk; and farm safety education. For FY2020, P.L. 116-94 provides $87.8 million for Smith-Lever 3(d) programs. For FY2021, the Administration is requesting $83.6 million, a reduction of 4.8%. Of this total, $69.0 million would support the Expanded Food and Nutrition Education Program (EFNEP), and $3.0 million would support the Federally-Recognized Tribes Extension Program. The National Agricultural Statistics Service conducts the quinquennial Census of Agriculture and provides official statistics on agricultural production and indicators of the economic and environmental status of the farm sector. NASS is one of the 13 principal statistical agencies of the Federal Statistical System of the United States. For FY2020, P.L. 116-94 provides $180.3 million to NASS, of which up to $45.3 million is reserved to support the Census of Agriculture. The Administration is requesting $177.5 million for NASS in FY2021, of which up to $46.3 million is to support the Census of Agriculture. NASS has begun preparing for the 2022 Census of Agriculture. The explanatory statement accompanying FY2020 appropriations ( H.R. 1865 ) commented on the Administration's FY2020 budget request, rejecting its proposals to eliminate and reduce specific ongoing activities. The Administration's request for FY2021 proposes increases for some programs, as well as reductions for the Acreage, Crop Production, and Grain Stocks program (reduced by $13.2 million) as well as the Chemical Use Program (reduced by $3.5 million). The Economic Research Service supports economic and social science analysis about agriculture, rural development, food, commodity markets, and the environment. It also collects and disseminates data concerning USDA programs and policies. Like NASS, ERS is one of the 13 principal statistical agencies of the Federal Statistical System of the United States. ERS headquarters is located in Washington, DC. In October 2019, USDA relocated the majority of ERS staff positions to Kansas City, MO. For FY2020, P.L. 116-94 provides $84.8 million for ERS activities. The Administration is requesting $62.1 million for FY2021, a 26.7% decrease. The Administration's budget request attributes $11.3 million of this decrease to its proposal to "discontinue research relative to farm, conservation and trade policy, and returns on investments in agricultural research and development." It proposes to eliminate research on special initiatives that include "research innovations for policy effectiveness, new energy sources ..., local and regional food markets, beginning farmers and ranchers, invasive species, and markets for environmental services." The Administration's budget request attributes $8.4 million of this decrease (and 52 staff years) to elimination of some research on food assistance, nutrition, and diet quality. Congress created the Office of the Chief Scientist in 2008 when it established the dual role of the Under Secretary for REE as the USDA Chief Scientist (7 U.S.C. Â§6971). The OCS purpose is to coordinate research programs and activities across USDA. Administratively, because it is situated within the Office of the Under Secretary of REE, OCS is a component of the Office of the Secretary (OSEC). Since its establishment, OCS has not received an independent appropriation. Rather, it has been funded via interagency agreement among the four REE agencies. The FY2021 President's budget request for OSEC includes the first separate request for OCS, in the amount of $6 million and 29 staff years. Two agencies of the Department of Commerce have major R&D programs: the National Institute of Standards and Technology (NIST) and the National Oceanic and Atmospheric Administration (NOAA). The mission of the National Institute of Standards and Technology is "to promote U.S. innovation and industrial competitiveness by advancing measurement science, standards, and technology in ways that enhance economic security and improve our quality of life." NIST research provides measurement, calibration, and quality assurance methods and techniques that support U.S. commerce, technological progress, product reliability, manufacturing processes, and public safety. NIST's responsibilities include the development, maintenance, and custodial retention of the national standards of measurement; providing the means and methods for making measurements consistent with those standards; and ensuring the compatibility of U.S. national measurement standards with those of other nations. The President is requesting $737.5 million for NIST in FY2021, a decrease of $296.5 million (28.7%) from the FY2020 enacted appropriation of $1,034.0 million. (See Table 13 .) NIST discretionary funding is provided through three accounts: Scientific and Technical Research and Services (STRS), Industrial Technology Services (ITS), and Construction of Research Facilities (CRF). The President's FY2021 request includes $652 million for R&D, standards coordination, and related services in the STRS account, a decrease of $102.0 million (13.5%) from the FY2020 enacted level. According to NIST, the reductions would be necessary to address the President's priorities: To meet the topline funding levels proposed in the FY 2021 President's Budget request and support the Administration's stated priorities for Industries of the Future (IoTF) in quantum information science, artificial intelligence, advanced communications, advanced manufacturing, and biotechnology â¦ NIST will have to make substantial reductions to its current R&D and program portfolio that impact work in advanced materials, physical infrastructure and resilience, and areas across NIST. The funding for the NIST laboratory programs will be reduced by $115.5 million and this reduction proposes the elimination of 391 employees. In particular, the budget proposes funding reductions in the following areas: Advanced Manufacturing and Material Measurements, down $37.5 million (31.3%) from FY2020, including a reduction of 178 positions. Fundamental Measurement, Quantum Science, and Measurement Dissemination, down $17.8 million (9.3%) from FY2020, including a reduction of 73 positions. According to NIST, "to prioritize work focused on advancing quantum science (including efforts focused on quantum networking) and transforming how NIST disseminates measurements through the NIST-on-A-Chip program, NIST will discontinue several measurement service and dissemination activities that are currently provided to our stakeholders in industry, government and academia." Advanced Communications, Networks, and Scientific Data Systems, down $35.8 million (52%) from FY2020, including 83 positions. Health and Biological Systems Measurements, down $3 million (8.6%) from FY2020. Physical Infrastructure and Resilience, down $16.4 million (28%) from FY2020, including 42 positions. NIST User Facilities, down $5 million (9.2%) from FY2020, including 15 positions. NIST is requesting $27.4 million for its Measurement Tools and Testbeds to Power the Industries of the Future (IotF) efforts, to create measurement tools and testbeds to support deployment of IotF technologies at scale. Of these funds, $25 million would support acceleration of the development and adoption of artificial intelligence, $1.4 million would support 5G standards development for telecommunication, and $1 million would support acceleration of efforts to develop profiles for Position, Navigation, and Timing. The FY2021 request would provide $25.3 million for the ITS account, down $136.7 million (84.4%) from the FY2020 enacted level. Within the ITS account, the request would provide no funding for the Manufacturing Extension Partnership (MEP) program, a reduction of $146.0 million from the FY2020 enacted level; MEP centers in each state would be required to become entirely self-supporting. In his FY2019 and FY2020 requests, President Trump also proposed ending federal funding for MEP; in his FY2018 request, the President sought $6.0 million "for an orderly shutdown of the program." The FY2021 request for ITS consists of $25.3 million for Manufacturing USA (also referred to as the National Network for Manufacturing Innovation or NNMI), $9.3 million (58.1%) higher than the FY2020 enacted level of $16.0 million. Of these funds, $11.2 million would be for continued support of NIST's first Manufacturing USA institute, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL); $9.1 million would be for the award of a second Manufacturing USA institute; and $5.0 million would be for coordination of the Manufacturing USA network. The President is requesting $60.2 million for the NIST CRF account for FY2021, down $57.8 million (49.0%) from the FY2020 enacted level. Part of the decrease ($36.5 million) in requested FY2021 funding is due to a proposed deferral of safety, capacity, maintenance, and major repairs projects from FY2021 to FY2022. The balance of the decrease would result from the effect of the Administration's proposed new funding approach on the renovation of NIST Building 1, in Boulder, CO. The National Oceanic and Atmospheric Administration conducts scientific research in areas such as ecosystems, atmosphere, global climate change, weather, and oceans; collects and provides data on the oceans and atmosphere; and manages coastal and marine organisms and environments. NOAA was created in 1970 by Reorganization Plan No. 4. The reorganization was intended to unify elements of the nation's environmental programs and to provide a systematic approach for monitoring, analyzing, and protecting the environment. NOAA's administrative structure is organized into six line offices: the National Ocean Service (NOS); National Marine Fisheries Service (NMFS); National Environmental Satellite, Data, and Information Service (NESDIS); National Weather Service (NWS); Office of Oceanic and Atmospheric Research (OAR); and the Office of Marine and Aviation Operations (OMAO). The line offices are supported by an additional office, Mission Support, which provides cross-cutting administrative functions related to education, planning, information technology, human resources, and infrastructure. Congress provides most of the discretionary funding for the line offices and Mission Support through two accounts: (1) Operations, Research, and Facilities, and (2) Procurement, Acquisition, and Construction. In 2010, NOAA published its Next Generation Strategic Plan . The strategic plan is organized into four categories of long-term goals: (1) climate adaptation and mitigation, (2) a weather-ready nation, (3) healthy oceans, and (4) resilient coastal communities and economies. The strategic plan also lists three groups of enterprise objectives related to (1) stakeholder engagement, (2) data and observations, and (3) integrated environmental modeling. The strategic plan serves as a guide for NOAA's R&D plan. The most recent R&D plan was published in 2013, and includes R&D objectives to reach strategic plan goals and objectives and targets to track progress toward R&D objectives over time. NOAA released a draft 2020-2026 R&D plan in June 2019. The draft plan identifies three vision areas: (1) reducing societal impacts from severe weather and other environmental phenomena, (2) sustainable use and stewardship of ocean and coastal resources, and (3) a robust and effective research, development, and transition enterprise. It is unclear when the draft plan will be finalized. For FY2021, President Trump requested $670.3 million in discretionary appropriations for NOAA R&D funding, a decrease of $301.6 million (31%) below the FY2020 enacted level of $972.0 million, and an increase of $19.2 million (3%) from the FY2020 request of $651.1 million. The President's FY2021 request for NOAA R&D was 14.5% of the total FY2021 NOAA requested amount of $4.634 billion. The FY2021 request includes $378.6 million for research (56.5% of the total requested for NOAA R&D), $94.9 million for development (14.1%), and $197.0 million (29.4%) for R&D equipment and facilities. Table 14 provides R&D amounts enacted in FY2020 and requested by the Administration for FY2021. OAR accounts for the majority of NOAA R&D in most years, including FY2021. The Administration requested $352.7 million for OAR R&D in FY2021, a decrease of $199.9 million (36.2%) below the FY2020 enacted funding level of $552.6 million and an increase of $17.6 million (5.3%) from the FY2020 request of $335.1 million. OAR conducts research in three major areas: (1) weather and air chemistry; (2) climate; and (3) oceans, coasts, and the Great Lakes. A significant portion of these efforts is implemented through OAR's laboratories and cooperative research institutes. The President requested $167.6 million for OAR labs and cooperative institutes in FY2021, $16.5 million (8.9%) less than the FY2020 enacted amount of $184.0 million and $2.1 million (1.2%) less than the FY2020 requested amount. Among other R&D activities, the Administration requested to terminate federal support of the National Sea Grant College Program and its related Marine Aquaculture Research program in FY2021, as it had in FY2020. The National Sea Grant College Program is composed of 33 university-based state programs and supports scientific research and stakeholder engagement to identify and solve problems faced by coastal communities. Congress provided $74 million to the National Sea Grant College Program and $13 million to the Marine Aquaculture Research program in FY2020. The Department of Veterans Affairs operates and maintains a national health care delivery system to provide eligible veterans with medical care, benefits, and social support. As part of the agency's mission, it seeks to advance medical R&D in areas most relevant to the diseases and conditions that affect the health care needs of veterans. The President is proposing $1.456 billion for VA R&D in FY2021, an increase of $58 million (4%) from FY2020 enacted levels. (See Table 15 .) According to the President's request, FY2021 strategic priorities for VA R&D include increasing the access of veterans to clinical trials; increasing the transfer and translation of VA R&D; and the effective use of VA data for veterans. Additionally, crosscutting priorities for VA R&D include efforts to treat veterans at risk of suicide and research to address chronic pain and opioid addiction, posttraumatic stress disorder, traumatic brain injury, precision oncology, and Gulf War illness and military exposures. VA R&D is funded through two accountsâthe Medical and Prosthetic Research account and the Medical Care Support account. The Medical Care Support account also includes non-R&D funding, and the amount of funding that will be allocated to support R&D through appropriations legislation is unclear unless funding is provided at the precise level of the request. In general, R&D funding levels from the Medical Care Support account are only known after the VA allocates its appropriations to specific activities and reports those figures. The FY2021 request includes $787 million for VA's Medical and Prosthetic Research account, a decrease of $37 million (5%) compared to FY2020 enacted levels. The request includes $669 million in funding for research supported by the agency's Medical Care Support account, an increase of $21 million (3%) compared to FY2020. The Medical Care Support account provides administrative and other support for VA researchers and R&D projects, including infrastructure maintenance. The Medical and Prosthetics R&D program is an intramural program managed by the Veteran Health Administration's Office of Research and Development (ORD) and conducted at VA Medical Centers and VA-approved sites nationwide. According to ORD, the mission of VA R&D is "to improve Veterans' health and well-being via basic, translational, clinical, health services, and rehabilitative research and to apply scientific knowledge to develop effective individualized care solutions for Veterans." ORD consists of four main research services, each headed by a director: Biomedical Laboratory R&D conducts preclinical research to understand life processes at the molecular, genomic, and physiological levels. Clinical Science R&D supports clinical trials and other human subjects research to determine the feasibility and effectiveness of new treatments such as drugs, therapies, or devices; compare existing therapies; and improve clinical care and practice. Health Services R&D conducts studies to identify and promote effective and efficient strategies to improve the quality and accessibility of the VA health system and patient outcomes, and to minimize health care costs. Rehabilitation R&D conducts research and develops novel approaches to improving the quality of life of impaired and disabled veterans. In addition to intramural support, VA researchers are eligible to obtain funding for their research from extramural sources, including other federal agencies, private foundations and health organizations, and commercial entities. According to the President's FY2021 budget request, these additional R&D resources are estimated at $540 million in FY2021. However, unlike other federal agencies, such as the National Institutes of Health and the Department of Defense, VA does not have the authority to support extramural R&D by providing research grants to colleges, universities, or other non-VA entities. Table 15 summarizes R&D program funding for VA in the Medical and Prosthetic Research and the Medical Care Support accounts. Table 16 details amounts to be spent in Designated Research Areas (DRAs), which VA describes as "areas of importance to our veteran patient population." Funding for research projects that span multiple areas may be included in several DRAs; thus, the amounts in Table 16 total to more than the appropriation or request for VA R&D. The Department of Transportation was established by the Department of Transportation Act (P.L. 89-670) on October 15, 1966. The primary purposes of DOT research and development activities as defined by Section 6019 of the Fixing America's Surface Transportation Act ( P.L. 11 4-94 ) are improving mobility of people and goods; reducing congestion; promoting safety; improving the durability and extending the life of transportation infrastructure; preserving the environment; and preserving the existing transportation system. Funding for DOT R&D is generally included in appropriations line items that also include non-R&D activities. The amount of funding provided by appropriations legislation that is allocated to R&D is unclear unless funding is provided at the precise level of the request. In general, R&D funding levels are known only after DOT agencies allocate their final appropriations to specific activities and report those figures. In FY2021, the Administration is requesting a total of $593.8 million for DOT R&D activities and facilities at the Federal Aviation Administration (FAA), the National Highway Traffic Safety Administration (NHTSA), the Federal Railroad Administration (FRA), the Pipeline and Hazardous Materials Safety Administration (PHMSA), and the Office of the Secretary (OST) (see Table 17 ). The Administration is not requesting funding for DOT R&D activities and facilities associated with the Federal Highway Administration (FHWA), the Federal Transit Administration (FTA), or the Federal Motor Carrier Safety Administration (FMCSA), citing the need for surface transportation reauthorization legislation. In FY2020, three DOT agenciesâFAA, NHTSA, and FHWAâaccounted for nearly 90% of DOT R&D funding. The President's FY2021 request of $446.9 million for R&D activities and facilities at FAA would be a decrease of $86 million (16.1%) from the FY2020 enacted amount. The request includes $170 million for the agency's Research, Engineering, and Development (RE&D) account, a reduction of $22.7 million (11.8%) from FY2020. Funding within the RE&D account seeks to improve aircraft safety through research in fields such as fire safety, advanced materials, propulsion systems, aircraft icing, and continued airworthiness, in addition to safety research related to unmanned aircraft systems and the integration of commercial space operations into the national airspace. The President is requesting $62.9 million in R&D and R&D facilities funding in FY2021 for NHTSA, $15.0 million (19.3%) below FY2020. NHTSA R&D focuses on automation and the study of human machine interfaces, advanced vehicle safety technology, ways of improving vehicle crashworthiness and crash avoidance, reducing unsafe driving behaviors, and alternative fuels vehicle safety. R&D activities are also supported by several other DOT components or agencies (see Table 17 ). The President's FY2021 request includes DOT R&D activities and facilities funding for: the Federal Railroad Administration, totaling $41.0 million, $0.4 million (1.0%) above the FY2020 enacted level of $40.6 million; the Pipeline and Hazardous Materials Safety Administration, totaling $24.5 million, the same amount as FY2020; and the Office of the Secretary, totaling $18.4 million, $8.5 million (31.7%) below the FY2020 level of $27.0 million. The Department of the Interior (DOI) was created to conserve and manage the nation's natural resources and cultural heritage, to provide scientific and other information about those resources, and to uphold "the nation's trust responsibilities or special commitments to American Indians, Alaska Natives, and affiliated island communities to help them prosper." DOI has a wide range of responsibilities, including, among other things, mapping, geological, hydrological, and biological science; migratory bird, wildlife, and endangered species conservation; surface-mined lands protection and restoration; and historic preservation. The Administration is requesting $12.8 billion in net discretionary funding for DOI in FY2021. Of that amount, $725 million is proposed for R&D, $248 million (25%) below the FY2020 estimated level of $973 million. The U.S. Geological Survey (USGS) is the only DOI component that conducts basic research. Funding for DOI R&D is generally included in appropriations line items that also include non-R&D activities. How much of the funding provided in appropriations legislation is allocated to R&D specifically is unclear unless funding is provided at the precise level of the request. In general, R&D funding levels are known only after DOI components allocate their appropriations to specific activities and report those figures. The President's FY2021 request also includes R&D funding for the following DOI components, none of which would receive an increase: Bureau of Reclamation (BOR): $76 million for FY2021, down $39 million (34%) from the FY2020 estimate. Bureau of Ocean Energy Management (BOEM): $93 million for FY2021, down $7 million (7%) from the FY2020 estimate. Fish and Wildlife Service (FWS): $15 million for FY2021, equal to the FY2020 estimate. National Park Service (NPS): $26 million for FY2021, equal to the FY2020 estimate. Bureau of Safety and Environmental Enforcement (BSEE): $25 million for FY2021, down $2 million (7%) from the FY2020 estimate. Bureau of Land Management (BLM): $21 million for FY2021, equal to the FY2020 estimate. Bureau of Indian Affairs (BIA): $5 million for FY2021, equal to the FY2020 estimate. Wildland Fire Management (WFM): No funding requested for R&D for FY2021. Office of Surface Mining Reclamation and Enforcement (OSMRE): $1 million for FY2021, equal to the FY2020 estimate. Table 18 summarizes FY2020 estimated R&D funding and the President's FY2021 R&D funding request for DOI components. The Department of Homeland Security (DHS) has identified five core missions: to prevent terrorism and enhance security, to secure and manage the borders, to enforce and administer immigration laws, to safeguard and secure cyberspace, and to ensure resilience to disasters. New technology resulting from research and development can contribute to achieving all these goals. The Directorate of Science and Technology (S&T) has primary responsibility for establishing, administering, and coordinating DHS R&D activities. Other components, such as the Countering Weapons of Mass Destruction Office, the U.S. Coast Guard, and the Transportation Security Administration, conduct R&D relating to their specific missions. The President's FY2021 budget request for DHS includes $439 million for activities identified as R&D. This would be a reduction of 19.6% from $546 million in FY2020. The total includes $340Â million for the R&D account in the S&T Directorate and smaller amounts for four other DHS components. See Table 19 . The S&T Directorate performs R&D in several laboratories of its own and funds R&D performed by the DOE national laboratories, industry, universities, and others. It also conducts testing and other technology-related activities in support of acquisitions by other DHS components. The Administration's FY2021 request of $340 million for the S&T Directorate R&D account would be a decrease of 19.5% from $422 million in FY2020. Five of the six thrust areas in the S&T Directorate's Research, Development, and Innovation budget line would decrease, by amounts ranging from 18.3% (Cyber Security/Information Analysis) to 32.4% (Chemical, Biological, and Explosives Defense), while funding for the sixth thrust area, Innovative Research and Foundational Tools, would increase by 35.2%. Funding for university centers of excellence would decrease from $37 million in FY2020 to $18 million in FY2021 (Congress rejected a similar proposal in the FY2020 budget). In addition to its R&D account, the S&T Directorate receives funding for laboratory facilities and other R&D-related expenses through two other accounts (not shown in the table). The total request for the directorate is $644 million, a decrease of 12.7% from $737 million in FY2020. The directorate's Procurement, Construction, and Improvements account would receive $19 million in the Administration's request (versus zero in FY2020) for closure of the Plum Island Animal Disease Centerâwhich is being replaced by the National Bio and Agro-Defense Facility (NBAF)âand for preparation of Plum Island itself for sale. The request for R&D in the Countering Weapons of Mass Destruction Office is $58 million, down from $69 million in FY2019. No funding is requested for the National Technical Nuclear Forensics program ($7 million in FY2020), which the Administration is proposing to transfer to the DOE National Nuclear Security Administration. The U.S. Environmental Protection Agency (EPA), the federal regulatory agency responsible for administering a number of environmental pollution control laws, funds a broad range of R&D activities to provide scientific tools and knowledge that support decisions relating to preventing, regulating, and abating environmental pollution. Since FY2006, Congress has funded EPA through the Interior, Environment, and Related Agencies appropriations acts. Appropriations for EPA R&D are generally included in line-items that also include non-R&D activities. Annual appropriations bills and the accompanying committee reports do not identify precisely how much funding provided in appropriations bills is allocated to EPA R&D alone. EPA determines its R&D funding levels in operation through allocating its appropriations to specific activities and reporting those amounts. The agency's Science and Technology (S&T) appropriations account funds much of EPA's scientific research activities, which include R&D conducted by the agency at its own laboratories and facilities, and R&D and related scientific research conducted by universities, foundations, and other nonfederal entities that receive EPA grants. The S&T account receives a base appropriation and a transfer from the Hazardous Substance Superfund (Superfund) account for research on more effective methods for remediating contaminated sites. EPA's Office of Research and Development (ORD) is the primary manager of R&D at EPA headquarters and laboratories around the country, as well as external R&D. A large portion of the S&T account funds EPA R&D activities managed by ORD, including research grants. Programs implemented by other offices within EPA also may have a research component, but the research component is not necessarily the primary focus of the program. As with the President's FY2020 budget request, the FY2021 request proposes reductions and eliminations of funding for FY2021 across a number of EPA programs and activities. The President's FY2021 request includes a total of $6.66 billion for EPA (after rescissions ), $2.40 billion (26.5%) less than the total $9.06 billion FY2020 enacted appropriations (no rescissions ) for EPA provided in Title II of the Further Consolidated Appropriations Act, 2020 ( P.L. 116- 94 ), and $435.6 million (7.0%) more than the FY2020 request of $6.22 billion for EPA (after rescissions ). Reductions proposed in the President's FY2021 request are distributed across EPA operational functions and activities as well as grants for states, tribes, and local governments. With the exception of the Building and Facilities account, the President's FY2021 request proposes funding reductions below FY2020 enacted levels for the nine other EPA appropriations accounts, although funding for some program areas within the accounts would remain constant or increase. Some Members of Congress expressed concerns regarding proposed reductions of funding for EPA scientific research programs during hearings on the President's FY2021 budget request. Similar proposed reductions in the FY2020 budget request were generally not included in the FY2020 enacted appropriations. Including a $19.1 million transfer from the Superfund account, the President's FY2021 budget request proposes $503.8 million for EPA's S&T account, $243.4 million (32.6%) less than the FY2020 enacted $747.2 million for the S&T account provided in P.L. 116-94 , which included a $30.7 million transfer from the Superfund. The FY2021 request would provide an increase of 4.8% for the S&T account compared to the FY2020 request of $480.8 million, which included a $17.8 million transfer from the Superfund account. Table 20 at the end of this section includes the President's FY2021 request for program areas and activities within EPA's S&T account as presented in EPA's FY2021 Congressional Budget Justification compared to the FY2020 enacted appropriations as reported in the Explanatory Statement accompanying P.L. 116-94 that includes the Department of Interior, Environment, and Related Agencies appropriations. House and Senate Appropriations Committee reports and explanatory statements accompanying recent fiscal year EPA proposed and enacted appropriations have not specified funding for all subprogram areas reported in EPA's budget justifications. S&T subprogram areas not directly reported in House and Senate Appropriations Committee reports are noted in Table 20 as "NR" (not reported). Additionally, the President's FY2018 through FY2021 budget requests and EPA's associated congressional budget justifications have modified the titles for some of the program areas relative to previous Administrations' budget requests and congressional committee reports' presentations. The House and Senate Appropriations Committees have generally adopted the modified program area titles as presented in the recent budget requests. As shown in Table 20 , with few exceptions the requested FY2021 amount for individual EPA program area and activity line items within the S&T account would be less than the FY2020 enacted appropriations. The FY2021 request did not propose to completely eliminate funding for the broader program areas; however, eliminations (no funding is requested for FY2021) are proposed for line-item activities below the program areas as indicated in Table 20 . These program areas include Atmospheric Protection Program (formerly GHG [greenhouse gas] Reporting Program and Climate Protection Program), Indoor Air Radon Program, and Reduce Risks from Indoor Air. For other program areas, proposed reductions in funding included eliminations of certain activities within those program areas. For example, the proposed reduction in funding for Research: Air and Energy, Research: Safe and Sustainable Water Resources, Research: Sustainable and Healthy Communities, and Research: Chemical Safety and Sustainability program areas for FY2021 included the proposed elimination of funding for the Science to Achieve Results (STAR) program. The FY2020 enacted appropriations for the S&T account included $6.0 million for Research: National Priorities within the S&T account for FY2020, an increase compared to $5.0 million included for FY2019. As in the previous Administration's fiscal year requests, the President's FY2021 budget request did not include funding for Research: National Priorities. The size and structure of the EPA's workforce has been a topic of debate during congressional committee hearings, particularly in recent fiscal years. "Workforce reshaping" was introduced in the FY2018 request and described as agency-wide organizational restructuring, "reprioritization of agency activities," and reallocation of resources. Workforce reshaping was most recently proposed in the FY2020 request. As with the FY2018 and FY2019 enacted appropriations, P.L. 116-94 did not fund the President's FY2020 request for EPA workforce reshaping for FY2020. The FY2021 request does not include similar funding for EPA workforce reshaping; however, according to the EPA's FY2021 Congressional budget justification, the number of full-time-equivalents (FTEs) would be reduced from 14,172.0 FTEs in FY2020 to 12,610.2 FTEs in FY2021. Appendix A. Acronyms and Abbreviations Appendix B. CRS Contacts for Agency R&D The following table lists the primary CRS experts on R&D funding for the agencies covered in this report.
President Trump's budget request for FY2021 includes approximately $142.2 billion for research and development (R&D) for FY2021, $13.8 billion (8.8%) below the FY2020 enacted level of $156.0 billion. In constant FY2020 dollars, the President's FY2021 R&D request would result in a decrease of $16.6 billion (10.6%) from the FY2020 level. F ederal Research and Development Funding, FY2019-FY2021 In billions of dollars In 2017, the Office of Management and Budget (OMB) adopted a change to the definition of development, applying a more narrow treatment that it describes as "experimental development." This change was intended to harmonize the reporting of U.S. R&D funding data with the approach used by other nations. The new definition is used in this report. Funding for R&D is concentrated in a few departments and agencies. In FY2020, five federal agencies received 93.2% of total federal R&D funding, with the Department of Defense (DOD, 41.4%) and the Department of Health and Human Services (HHS, 26.2%) combined accounting for more than two-thirds of all federal R&D funding. In the FY2021 request, the top five R&D agencies would account for 93.8%, with DOD accounting for 42.1% and HHS for 26.6%. Under the President's FY2021 budget request, nearly all federal agencies would see their R&D funding decline relative to FY2020. The only exception is the Department of Veterans Affairs, which would increase by $38 million (2.9%) in FY2021 to $1.351 billion. The largest dollar reductions in R&D funding would be made to the DOD (down $4.713 billion), the Department of Energy (down $3.168 billion), and HHS (down $2.843 billion). The largest percentage declines in R&D funding would be at the Department of Transportation (down 47.6%), the Environmental Protection Agency (down 35.4%), and Department of the Interior (down 25.5%) The President's FY2021 budget request would reduce funding for basic research by $2.822 billion (6.5%), applied research by $5.125 billion (11.7%), development by $3.466 billion (5.5%), and facilities and equipment by $2.375 billion (39.6%). Several multiagency R&D initiatives continue under the President's FY2021 budget. Some activities supporting these initiatives are discussed in agency budget justifications and are reported in the agency analyses in this report. However, comprehensive aggregate budget information on these initiatives will likely not be available until budget supplements for each are released later in the year. The request represents the President's R&D priorities. Congress may opt to agree with none, part, or all of the request, and it may express different priorities through the appropriations process. In recent years, Congress has completed the annual appropriations process after the start of the fiscal year. Completing the process after the start of the fiscal year and the accompanying use of continuing resolutions can affect agencies' execution of their R&D budgets, including the delay or cancellation of planned R&D activities and the acquisition of R&D-related equipment. It is not yet clear how the national response to the Coronavirus Disease 2019 (COVID-19) pandemic will affect Administration and congressional priorities for FY2021 R&D funding, or the congressional authorization and appropriations processes for enacting that funding.